Cargando…
Dynamic Up-Regulation of PD-L1 in the Progression of Oral Squamous Cell Carcinoma
The introduction of immune checkpoint inhibition for recurrent and metastatic head and neck cancer has brought a new treatment option for patients suffering from advanced oral cancers without a chance for curation using surgery or radiotherapy. The application of immune checkpoint inhibitors in most...
Autores principales: | Steen, Sonja, Semmelmayer, Karl, Flechtenmacher, Christa, Hoffmann, Jürgen, Freier, Kolja, Horn, Dominik, Hess, Jochen, Freudlsperger, Christian, Moratin, Julius |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671831/ https://www.ncbi.nlm.nih.gov/pubmed/38003576 http://dx.doi.org/10.3390/ijms242216386 |
Ejemplares similares
-
Digital Pathology Scoring of Immunohistochemical Staining Reliably Identifies Prognostic Markers and Anatomical Associations in a Large Cohort of Oral Cancers
por: Moratin, Julius, et al.
Publicado: (2021) -
A six-gene expression signature related to angiolymphatic invasion is associated with poor survival in laryngeal squamous cell carcinoma
por: Metzger, Karl, et al.
Publicado: (2020) -
Clinical outcome and prognostic factors in recurrent oral squamous cell carcinoma after primary surgical treatment: a retrospective study
por: Zittel, Sven, et al.
Publicado: (2021) -
Correction to: A six-gene expression signature related to angiolymphatic invasion is associated with poor survival in laryngeal squamous cell carcinoma
por: Metzger, Karl, et al.
Publicado: (2021) -
Free-Flap Reconstruction in Early-Stage Squamous Cell Carcinoma of the Oral Cavity—A Prospective Monocentric Trial to Evaluate Oncological Outcome and Quality of Life
por: Moratin, Julius, et al.
Publicado: (2023)